BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11603281)

  • 1. Salvia miltiorrhiza and ischemic diseases.
    Ji XY; Tan BK; Zhu YZ
    Acta Pharmacol Sin; 2000 Dec; 21(12):1089-94. PubMed ID: 11603281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis.
    Wang G; Wang L; Xiong ZY; Mao B; Li TQ
    Med Sci Monit; 2006 Jan; 12(1):SR1-7. PubMed ID: 16369479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of randomized controlled trials comparing compound danshen dripping pills and isosorbide dinitrate in treating angina pectoris.
    Yao Y; Feng Y; Lin W
    Int J Cardiol; 2015 Mar; 182():46-7. PubMed ID: 25585358
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction.
    Sun J; Huang SH; Tan BK; Whiteman M; Zhu YC; Wu YJ; Ng Y; Duan W; Zhu YZ
    Life Sci; 2005 Apr; 76(24):2849-60. PubMed ID: 15808885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat.
    Nie R; Xia R; Zhong X; Xia Z
    Can J Physiol Pharmacol; 2007 Oct; 85(10):1012-9. PubMed ID: 18066102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Chinese patent medicine Salvia miltiorrhiza depside salts for infusion combined with conventional treatment for patients with angina pectoris: A systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Xie Y; Liao X; Jia Q; Chai Y
    Phytomedicine; 2017 Feb; 25():100-117. PubMed ID: 28190464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion.
    Han JY; Fan JY; Horie Y; Miura S; Cui DH; Ishii H; Hibi T; Tsuneki H; Kimura I
    Pharmacol Ther; 2008 Feb; 117(2):280-95. PubMed ID: 18048101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials.
    Jia Y; Huang F; Zhang S; Leung SW
    Int J Cardiol; 2012 Jun; 157(3):330-40. PubMed ID: 21251721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Duan W; Yu XQ; Wen JY; Chowbay B; Li CG; Sheu FS; Chan E; Zhou SF
    Neurosci Lett; 2007 May; 417(3):261-5. PubMed ID: 17397998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exploration on the clinical effect and mechanism of Herba Rhodobryi Rosei in treating ischemic heart diseases].
    Gao GQ; Wang GW; Zhang HK; Li D; Liu J; Ma Y; Wang Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Oct; 24(10):929-31. PubMed ID: 15553831
    [No Abstract]   [Full Text] [Related]  

  • 11. Indigenous free radical scavenger MAK 4 and 5 in angina pectoris. Is it only a placebo?
    Dogra J; Grover N; Kumar P; Aneja N
    J Assoc Physicians India; 1994 Jun; 42(6):466-7. PubMed ID: 7852231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of Danshen.
    Cheng TO
    Int J Cardiol; 2007 Sep; 121(1):9-22. PubMed ID: 17363091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke.
    Tzen JT; Jinn TR; Chen YC; Li FY; Cheng FC; Shi LS; She HKh; Chen BC; Hsieh V; Tu ML
    Acta Pharmacol Sin; 2007 May; 28(5):609-15. PubMed ID: 17439716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.
    Zhou L; Zuo Z; Chow MS
    J Clin Pharmacol; 2005 Dec; 45(12):1345-59. PubMed ID: 16291709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the vasorelaxant effect of Danshen (Salvia miltiorrhiza) in rat knee joints.
    Lam FY; Ng SC; Cheung JH; Yeung JH
    J Ethnopharmacol; 2006 Apr; 104(3):336-44. PubMed ID: 16266795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protection on myocardial ischemia and reperfusion injury by Salvia miltiorrhiza hairy root in isolated Langendorff rat hearts].
    Wang L; Lv D; Liang R; Huang L; Yuan Y
    Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(14):1848-51. PubMed ID: 19894523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of natural products on ischemic heart diseases and cardiovascular system.
    Sun J; Tan BK; Huang SH; Whiteman M; Zhu YZ
    Acta Pharmacol Sin; 2002 Dec; 23(12):1142-51. PubMed ID: 12466052
    [No Abstract]   [Full Text] [Related]  

  • 20. Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases.
    Chen W; Chen G
    Curr Pharm Des; 2017; 23(34):5125-5135. PubMed ID: 28828985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.